Compare Cronos Group Inc (CRON) vs Lithium Americas Corp (LAC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cronos Group Inc vs Lithium Americas Corp — how do they compare? Cronos Group Inc trades at $3.22 (market cap $1.18B), while Lithium Americas Corp trades at $2.35 (market cap $850.38M). The key difference: Cronos Group Inc is the larger of the two by market cap, and Cronos Group Inc is trading nearer its 52-week high, Lithium Americas Corp nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Cronos Group Inc for 22 Days and Lithium Americas Corp for 27 Days on average.
| CRON | LAC | |
|---|---|---|
Market Cap | $1.18B | $850.38M |
Volume | 968,037 | 8,804,637 |
Sector | Health | Basic Materials |
52-Week High | $3.55 | $10.05 |
52-Week Low | $2.30 | $2.36 |
Typical Hold Time | 22 Days | 27 Days |
Enterprise Value | $387.62M | $1.19B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRON trades at $3.24, down 1.37% today amid a bearish technical signal. Recent quarterly earnings show beats in Q1 and Q2 2026, with revenue growth from $118M in 2024 to $147M in 2025. The company reported a net loss of $9.45M in 2025 but projects a profit of $70M for 2026. Analyst sentiment is mixed with a 20% buy rating. News highlights focus on international expansion and a recent Investor Day outlining growth strategies.
Outlook is cautiously optimistic given projected profitability in 2026 and strong cash reserves, but risks include sustained negative cash flow and competitive pressures. The stock's valuation metrics like P/E of 16.95 and P/S of 6.84 suggest moderate pricing relative to peers, though high EV/EBITDA of 43 indicates premium expectations.
Lithium Americas (LAC) trades at $2.34, down 2.9% on the day, with a bearish technical signal from moving averages but bullish oscillators. The company shows negative profitability metrics with ROE at -9.56% and ROA at -3.99%, though it has beaten earnings expectations in recent quarters. Cash flow remains supported by financing activities as the company invests heavily in Thacker Pass development. Analyst consensus is mixed with 7 buy ratings and 8 hold ratings, with a $4.00 price target representing 71% upside potential.
LAC presents a high-risk, high-reward opportunity as it transitions from development to execution phase. The primary catalyst is successful construction and operation of Thacker Pass, but investors face significant execution risk, negative cash flow from operations, and lithium price volatility. The stock trades at a discount to book value (P/B 0.6), offering potential upside if operational milestones are met.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →About Lithium Americas Corp
Lithium Americas is a resource company focused on developing the Thacker Pass project in Nevada, the largest known lithium resource in the US. It aims to become a major supplier for the electric vehicle battery market.
Read more on LAC →
